Table 1: Demographic and clinical characteristics for patients.
|
Parameters |
N (%) |
Etiology of renal diseases |
Hypertension |
19 (31.7%) |
Diabetes mellitus |
16 (26.7%) |
|
Chronic glomerulonephritis |
4 (6.7%) |
|
Analgesic nephropathy |
5 (8.3%) |
|
Others* |
10 (16.6%) |
|
Unknown |
6 (10%) |
|
Comorbid diseases |
Diabetes mellitus |
18 (30%) |
Liver disease |
12 (20%) |
|
Chronic lung disease |
5 (8.3%) |
|
Coronary arterial disease |
8 (13.3%) |
|
Prepheral arterial disease |
5 (8.3%) |
|
Medications |
RAS blockers |
27 (45%) |
CCB |
21 (35%) |
|
BB |
17 (28.3%) |
|
Aspirin |
9 (15%) |
|
Vitamin D |
33 (55%) |
|
ESA |
39 (65%) |
|
Echocardiographic abnormalities |
43 (71.7%) |
|
Left ventricular hypertrophy |
42 (70%) |
|
Left ventricular dilatation |
13 (21.7%) |
|
Systolic dysfunction |
25 (41.7%) |
|
Left atrial dilatation |
33 (55%) |
|
Aortic annulus dilatation |
19 (31.7%) |
|
Thyroid functions abnormalities |
47 (78.3%) |
|
Low total T3 |
42 (70%) |
|
Low total T4 |
36 (60%) |
|
Elevated TSH |
12 (20%) |
SBP: Systolic
Blood Pressure; DBP: Diastolic Blood
Pressure; BMI: Body Mass Index; RAS: Renin-Angiotensin System; BB: Beta
Blockers; CCB: Calcium Channel Blockers; ESA: Erythropiotin-Stimulating Agent.
*Other causes of renal failure
include aquired obstructive uropathy, polysystic kidney disease, gouty
nephropathy, chronic polynephritis, lupus nephritis.